Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002021199 | SCV002299192 | uncertain significance | not provided | 2021-07-14 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with PDE6A-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This variant is present in population databases (rs750763552, ExAC 0.001%). This sequence change replaces leucine with proline at codon 549 of the PDE6A protein (p.Leu549Pro). The leucine residue is highly conserved and there is a moderate physicochemical difference between leucine and proline. |